MicroRNAs in human glioblastoma: From bench to beside

Frontiers in Bioscience - Landmark

Volumn 20, Issue 1, 2015, Pages 105-118

  Wang, Hongxiang ^a   Xu, Tao ^a   Jiang, Ying ^a   Yan, Yong ^a   Qin, Rong ^a   Chen, Juxiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biogenesis; Glioblastoma; miRNA; Review; Signaling pathway; Therapy

Indexed keywords

MICRORNA; TUMOR MARKER;

BRAIN TUMOR; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84918812634     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4300     Document Type: Review

References (101)

1. J. A. Schwartzbaum, J. L. Fisher, K. D. Aldape and M. Wrensch: Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9), 494-503; quiz 1 p following 516 (2006) Doi not found.
2. S. K. Patrick Y. Wen: Malignant Gliomas in Adults. N Engl J Med (359), 492-507 (2008) Doi not found.
3. R. Bonavia, M. M. Inda, W. K. Cavenee and F. B. Furnari: Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 71(12), 4055-60 (2011) DOI: 10.1158/0008-5472.CAN-11-0153
4. E. G. Van Meir, C. G. Hadjipanayis, A. D. Norden, H. K. Shu, P. Y. Wen and J. J. Olson: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60(3), 166-93 (2010) DOI: 10.3322/caac.20069
5. L. He and G. J. Hannon: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7), 522-31 (2004) DOI: 10.1038/nrg1379
6. D. P. Bartel: MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-33 (2009) DOI: 10.1016/j.cell.2009.01.002
7. D. P. Bartel: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281-97 (2004) DOI: 10.1016/S0092-8674(04)00045-5
8. J. T. Mendell: MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4(9), 1179-84 (2005) DOI: 10.4161/cc.4.9.2032
9. E. V. Makeyev, J. Zhang, M. A. Carrasco and T. Maniatis: The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative premRNA splicing. Mol Cell 27(3), 435-48 (2007) DOI: 10.1016/j.molcel.2007.07.015
10. G. M. Schratt, F. Tuebing, E. A. Nigh, C. G. Kane, M. E. Sabatini, M. Kiebler and M. E. Greenberg: A brain-specific microRNA regulates dendritic spine development. Nature 439(7074), 283-9 (2006) DOI: 10.1038/nature04367
11. J. S. Nowak and G. Michlewski: miRNAs in development and pathogenesis of the nervous system. Biochem Soc Trans 41(4), 815-20 (2013) DOI: 10.1042/BST20130044
12. M. V. Iorio and C. M. Croce: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27(34), 5848-56 (2009) DOI: 10.1200/JCO.2009.24.0317
13. H. Li and B. B. Yang: Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol Sin 34(7), 870-9 (2013) DOI: 10.1038/aps.2013.35
14. A. Besse, J. Sana, P. Fadrus and O. Slaby: MicroRNAs involved in chemo- and radioresistance of high-grade gliomas. Tumour Biol 34(4), 1969-78 (2013) DOI: 10.1007/s13277-013-0772-5
15. Y. Zhang, A. Dutta and R. Abounader: The role of microRNAs in glioma initiation and progression. Front Biosci (Landmark Ed) 17, 700-12 (2012) DOI: 10.2741/3952
16. A. Nikaki, C. Piperi and A. G. Papavassiliou: Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin Investig Drugs 21(10), 1475-88 (2012) DOI: 10.1517/13543784.2012.710199
17. B. Zhang, X. Pan, G. P. Cobb and T. A. Anderson: microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1), 1-12 (2007) DOI: 10.1016/j.ydbio.2006.08.028
18. C. M. Croce and G. A. Calin: miRNAs, cancer, and stem cell division. Cell 122(1), 6-7 (2005) DOI: 10.1016/j.cell.2005.06.036
19. J. S. Yang and E. C. Lai: Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 43(6), 892-903 (2011) DOI: 10.1016/j.molcel.2011.07.024
20. J. Winter, S. Jung, S. Keller, R. I. Gregory and S. Diederichs: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11(3), 228-34 (2009) DOI: 10.1038/ncb0309-228
21. R. Yi, Y. Qin, I. G. Macara and B. R. Cullen: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24), 3011-6 (2003) DOI: 10.1101/gad.1158803
22. J. Winter and S. Diederichs: MicroRNA biogenesis and cancer. Methods Mol Biol 676, 3-22 (2011) DOI: 10.1007/978-1-60761-863-8-1
23. B. Chen, H. Li, X. Zeng, P. Yang, X. Liu, X. Zhao and S. Liang: Roles of microRNA on cancer cell metabolism. J Transl Med 10, 228 (2012) DOI: 10.1186/1479-5876-10-228
24. N. Pencheva and S. F. Tavazoie: Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15(6), 546-54 (2013) DOI: 10.1038/ncb2769
25. G. Shen, X. Li, Y. F. Jia, G. A. Piazza and Y. Xi: Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin 34(3), 336-41 (2013) DOI: 10.1038/aps.2012.195
26. N. Cancer Genome Atlas Research: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216), 1061-8 (2008) DOI: 10.1038/nature07385
27. M. Karsy, E. Arslan and F. Moy: Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme. Genes Cancer 3(1), 3-15 (2012) DOI: 10.1177/1947601912448068
28. J. Novakova, O. Slaby, R. Vyzula and J. Michalek: MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386(1), 1-5 (2009) DOI: 10.1016/j.bbrc.2009.06.034
29. A. M. Omuro, S. Faivre and E. Raymond: Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther 6(7), 1909-19 (2007) DOI: 10.1158/1535-7163.MCT-07-0047
30. P. Y. Wen, E. Q. Lee, D. A. Reardon, K. L. Ligon and W. K. Alfred Yung: Current clinical development of PI3K pathway inhibitors in glioblastoma. Neuro Oncol 14(7), 819-29 (2012) DOI: 10.1093/neuonc/nos117
31. C. Krakstad and M. Chekenya: Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9, 135 (2010) DOI: 10.1186/1476-4598-9-135
32. J. A. Chan, A. M. Krichevsky and K. S. Kosik: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14), 6029-33 (2005) DOI: 10.1158/0008-5472.CAN-05-0137
33. X. Zhou, Y. Ren, L. Moore, M. Mei, Y. You, P. Xu, B. Wang, G. Wang, Z. Jia, P. Pu, W. Zhang and C. Kang: Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90(2), 144-55 (2010) DOI: 10.1038/labinvest.2009.126
34. Y. Ren, X. Zhou, M. Mei, X. B. Yuan, L. Han, G. X. Wang, Z. F. Jia, P. Xu, P. Y. Pu and C. S. Kang: MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 10, 27 (2010) DOI: 10.1186/1471-2407-10-27
35. D. Yin, S. Ogawa, N. Kawamata, A. Leiter, M. Ham, D. Li, N. B. Doan, J. W. Said, K. L. Black and H. Phillip Koeffler: miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene 32(9), 1155-63 (2013) DOI: 10.1038/onc.2012.132
36. Y. Lu, M. Chopp, X. Zheng, M. Katakowski, B. Buller and F. Jiang: MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep 29(1), 67-72 (2013) Doi not found.
37. X. Zheng, F. Jiang, M. Katakowski, S. N. Kalkanis, X. Hong, X. Zhang, Z. G. Zhang, H. Yang and M. Chopp: Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci 98(5), 674-84 (2007) DOI: 10.1111/j.1349-7006.2007.00440.x
38. X. Zheng, F. Jiang, M. Katakowski, X. Zhang, H. Jiang, Z. G. Zhang and M. Chopp: Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. Cancer Lett 265(2), 177-87 (2008) DOI: 10.1016/j.canlet.2008.02.023
39. X. Zheng, F. Jiang, M. Katakowski, Y. Lu and M. Chopp: ADAM17 promotes glioma cell malignant phenotype. Mol Carcinog 51(2), 150-64 (2012) DOI: 10.1002/mc.20772
40. J. Boudeau, A. F. Baas, M. Deak, N. A. Morrice, A. Kieloch, M. Schutkowski, A. R. Prescott, H. C. Clevers and D. R. Alessi: MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22(19), 5102-5114 (2003) DOI: 10.1093/emboj/cdg490
41. M. Brajenovic, G. Joberty, B. Kuster, T. Bouwmeester and G. Drewes: Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem 279(13), 12804-11 (2004) DOI: 10.1074/jbc.M312171200
42. A. F. Baas, J. Boudeau, G. P. Sapkota, L. Smit, R. Medema, N. A. Morrice, D. R. Alessi and H. C. Clevers: Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22(12), 3062-72 (2003) DOI: 10.1093/emboj/cdg292
43. Y. Tian, Y. Nan, L. Han, A. Zhang, G. Wang, Z. Jia, J. Hao, P. Pu, Y. Zhong and C. Kang: MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol 40(4), 1105-12 (2012) Doi not found.
44. W. Wang, L. X. Dai, S. Zhang, Y. Yang, N. Yan, P. Fan, L. Dai, H. W. Tian, L. Cheng, X. M. Zhang, C. Li, J. F. Zhang, F. Xu, G. Shi, X. L. Chen, T. Du, Y. M. Li, Y. Q. Wei and H. X. Deng: Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo. Neoplasma 60(3), 274-83 (2013) DOI: 10.4149/neo-2013-036
45. B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E. A. Chiocca, S. Lawler and B. Purow: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68(10), 3566-72 (2008) DOI: 10.1158/0008-5472.CAN-07-6639
46. P. Ohgaki H Fau - Kleihues and P. Kleihues: Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100(12), 2235-2241 (2009) DOI: 10.1111/j.1349-7006.2009.01308.x
47. T. F. Masui K Fau - Cloughesy, P. S. Cloughesy Tf Fau - Mischel and P. S. Mischel: Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies. Neuropathol Appl Neurobiol 38(3): 271-91 (2012) DOI: 10.1111/j.1365-2990.2011.01238.x
48. L. Chen, R. Zhang, P. Li, Y. Liu, K. Qin, Z. Q. Fa, Y. J. Liu, Y. Q. Ke and X. D. Jiang: P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Neurosci Lett 534, 327-32 (2013) DOI: 10.1016/j.neulet.2012.11.047
49. J. N. Rich and D. D. Bigner: Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3(5), 430-46 (2004) DOI: 10.1038/nrd1380
50. F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, L. Chin, R. A. DePinho and W. K. Cavenee: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21(21), 2683-710 (2007) DOI: 10.1101/gad.1596707
51. S. Tanaka, D. N. Louis, W. T. Curry, T. T. Batchelor and J. Dietrich: Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10(1), 14-26 (2013) DOI: 10.1038/nrclinonc.2012.204
52. D. N. Louis: The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53(1), 11-21 (1994) DOI: 10.1097/00005072-199401000-00002
53. S. Luan, L. Sun and F. Huang: MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res 41(2), 67-74 (2010) DOI: 10.1016/j.arcmed.2010.02.007
54. T. C. Chang, E. A. Wentzel, O. A. Kent, K. Ramachandran, M. Mullendore, K. H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C. J. Lowenstein, D. E. Arking, M. A. Beer, A. Maitra and J. T. Mendell: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5) 745-52 (2007) DOI: 10.1016/j.molcel.2007.05.010
55. Y. Li, F. Guessous, Y. Zhang, C. Dipierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T. D. Schmittgen, B. Lopes, D. Schiff, B. Purow and R. Abounader: MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69(19), 7569-76 (2009) DOI: 10.1158/0008-5472.CAN-09-0529
56. E. C. Park, G. Kim, J. Jung, K. Wang, S. Lee, S. S. Jeon, Z. W. Lee, S. I. Kim, S. Kim, Y. T. Oh, J. H. Shin, H. S. Jang, B. O. Choi and G. H. Kim: Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. OMICS 17(5), 259-68 (2013) DOI: 10.1089/omi.2012.0065
57. T. Papagiannakopoulos, A. Shapiro and K. S. Kosik: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68(19), 8164-72 (2008) DOI: 10.1158/0008-5472.CAN-08-1305
58. S. Polager and D. Ginsberg: p53 and E2f: partners in life and death. Nat Rev Cancer 9(10), 738-48 (2009) DOI: 10.1038/nrc2718
59. W. Hui, L. Yuntao, L. Lun, L. WenSheng, L. ChaoFeng, H. HaiYong and B. Yueyang: MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 8(1), e54932 (2013) DOI: 10.1371/journal.pone.0054932
60. D. G. Johnson and C. L. Walker: Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39, 295-312 (1999) DOI: 10.1146/annurev.pharmtox.39.1.295
61. G. K. Schwartz and M. A. Shah: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23(36), 9408-21 (2005) DOI: 10.1200/JCO.2005.01.5594
62. A. Zhang, J. Hao, K. Wang, Q. Huang, K. Yu, C. Kang, G. Wang, Z. Jia, L. Han and P. Pu: Down-regulation of miR-106b suppresses the growth of human glioma cells. J Neurooncol 112(2), 179-89 (2013) DOI: 10.1007/s11060-013-1061-2
63. S. M. Chen, H. C. Chen, S. J. Chen, C. Y. Huang, P. Y. Chen, T. W. Wu, L. Y. Feng, H. C. Tsai, T. N. Lui, C. Hsueh and K. C. Wei: MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. World J Surg Oncol 11, 87 (2013) DOI: 10.1186/1477-7819-11-87
64. S. Qiu, D. Huang, D. Yin, F. Li, X. Li, H. F. Kung and Y. Peng: Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Biochim Biophys Acta 1832(10), 1697-707 (2013) DOI: 10.1016/j.bbadis.2013.05.015
65. M. K. Nicholas, R. V. Lukas, S. Chmura, B. Yamini, M. Lesniak and P. Pytel: Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin Oncol 38(2), 243-53 (2011) DOI: 10.1053/j.seminoncol.2011.01.009
66. H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P. L. Di Patre, C. Burkhard, D. Schuler, N. M. Probst-Hensch, P. C. Maiorka, N. Baeza, P. Pisani, Y. Yonekawa, M. G. Yasargil, U. M. Lutolf and P. Kleihues: Genetic pathways to glioblastoma: a population-based study. Cancer Res 64(19), 6892-9 (2004) DOI: 10.1158/0008-5472.CAN-04-1337
67. Z. Wu, L. Wang, G. Li, H. Liu, F. Fan, Z. Li, Y. Li and G. Gao: Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma. Mol Cell Biochem 384(1-2), 263-8 (2013) DOI: 10.1007/s11010-013-1805-5
68. S. Lu, S. Wang, S. Geng, S. Ma, Z. Liang and B. Jiao: Increased expression of microRNA-17 predicts poor prognosis in human glioma. J Biomed Biotechnol 2012, 970761 (2012) DOI: 10.1155/2012/970761
69. L. Jiang, P. Mao, L. Song, J. Wu, J. Huang, C. Lin, J. Yuan, L. Qu, S. Y. Cheng and J. Li: miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177(1), 29-38 (2010) DOI: 10.2353/ajpath.2010.090812
70. S. Lu, S. Wang, S. Geng, S. Ma, Z. Liang and B. Jiao: Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clin Transl Oncol 15(7), 569-74 (2013) DOI: 10.1007/s12094-012-0972-2
71. J. Jiang, X. Sun, W. Wang, X. Jin, X. Bo, Z. Li, A. Bian, J. Jiu, X. Wang, D. Liu, X. Hui, Y. Wang, A. Wang and L. Ding: Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 29(5), 3472-7 (2012) DOI: 10.1007/s12032-012-0259-z
72. G. Li, Z. Zhang, Y. Tu, T. Jin, H. Liang, G. Cui, S. He and G. Gao: Correlation of microRNA-372 upregulation with poor prognosis in human glioma. Diagn Pathol 8, 1 (2013) DOI: 10.1186/1746-1596-8-1
73. B. Sun, B. Pu, D. Chu, X. Chu, W. Li and D. Wei: MicroRNA-650 expression in glioma is associated with prognosis of patients. J Neurooncol 115(3), 375-80 (2013) DOI: 10.1007/s11060-013-1243-y
74. J. He, Y. Deng, G. Yang and W. Xie: MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma. J Surg Oncol 108(2), 121-5 (2013) DOI: 10.1002/jso.23315
75. C. Chang, H. Shi, C. Wang, J. Wang, N. Geng, X. Jiang and X. Wang: Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neurosci Lett 531(2), 204-8 (2012) DOI: 10.1016/j.neulet.2012.10.021
76. Z. Wu, L. Sun, H. Wang, J. Yao, C. Jiang, W. Xu and Z. Yang: MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma. PLoS One 7(10), e47270 (2012) DOI: 10.1371/journal.pone.0047270
77. Y. Guan, M. Mizoguchi, K. Yoshimoto, N. Hata, T. Shono, S. O. Suzuki, Y. Araki, D. Kuga, A. Nakamizo, T. Amano, X. Ma, K. Hayashi and T. Sasaki: MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res 16(16), 4289-97 (2010) DOI: 10.1158/1078-0432.CCR-10-0207
78. R. Lakomy, J. Sana, S. Hankeova, P. Fadrus, L. Kren, E. Lzicarova, M. Svoboda, H. Dolezelova, M. Smrcka, R. Vyzula, J. Michalek, M. Hajduch and O. Slaby: MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102(12), 2186-90 (2011) DOI: 10.1111/j.1349-7006.2011.02092.x
79. W. Zhang, J. Zhang, W. Yan, G. You, Z. Bao, S. Li, C. Kang, C. Jiang, Y. You, Y. Zhang, C. C. Chen, S. W. Song and T. Jiang: Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer 119(4), 814-24 (2013) DOI: 10.1002/cncr.27826
80. S. Srinivasan, I. R. Patric and K. Somasundaram: A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 6(3), e17438 (2011) DOI: 10.1371/journal.pone.0017438
81. R. Li, K. Gao, H. Luo, X. Wang, Y. Shi, Q. Dong, W. Luan and Y. You: Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma. J Exp Clin Cancer Res 33, 9 (2014) DOI: 10.1186/1756-9966-33-9
82. S. Lian, R. Shi, T. Bai, Y. Liu, W. Miao, H. Wang, X. Liu and Y. Fan: Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1. Curr Pharm Des 19(35), 6382-9 (2013) DOI: 10.2174/13816128113199990509
83. Z. Jia, K. Wang, G. Wang, A. Zhang and P. Pu: MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7. PLoS One 8(1), e55008 (2013) DOI: 10.1371/journal.pone.0055008
84. C. G. Dong, W. K. Wu, S. Y. Feng, X. J. Wang, J. F. Shao and J. Qiao: Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol 41(3), 1005-12 (2012) Doi not found.
85. M. Li, J. Li, L. Liu, W. Li, Y. Yang and J. Yuan: MicroRNA in Human Glioma. Cancers (Basel) 5(4), 1306-31 (2013) DOI: 10.3390/cancers5041306
86. M. Mizoguchi, Y. Guan, K. Yoshimoto, N. Hata, T. Amano, A. Nakamizo and T. Sasaki: Clinical implications of microRNAs in human glioblastoma. Front Oncol 3, 19 (2013) DOI: 10.3389/fonc.2013.00019
87. R. Garzon, G. Marcucci and C. M. Croce: Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9(10), 775-89 (2010) DOI: 10.1038/nrd3179
88. Y. Ren, C. S. Kang, X. B. Yuan, X. Zhou, P. Xu, L. Han, G. X. Wang, Z. Jia, Y. Zhong, S. Yu, J. Sheng and P. Y. Pu: Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed 21(3), 303-14 (2010) DOI: 10.1163/156856209X415828
89. Y. P. Yang, Y. Chien, G. Y. Chiou, J. Y. Cherng, M. L. Wang, W. L. Lo, Y. L. Chang, P. I. Huang, Y. W. Chen, Y. H. Shih, M. T. Chen and S. H. Chiou: Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 33(5), 1462-76 (2012) DOI: 10.1016/j.biomaterials.2011.10.071
90. G. Yang, R. Zhang, X. Chen, Y. Mu, J. Ai, C. Shi, Y. Liu, L. Sun, N. G. Rainov, H. Li, B. Yang and S. Zhao: MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 89(10), 1037-50 (2011) DOI: 10.1007/s00109-011-0775-x
91. D. W. Dai, Q. Lu, L. X. Wang, W. Y. Zhao, Y. Q. Cao, Y. N. Li, G. S. Han, J. M. Liu and Z. J. Yue: Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. BMC Cancer 13, 478 (2013) DOI: 10.1186/1471-2407-13-478
92. J. He, W. Zhang, Q. Zhou, T. Zhao, Y. Song, L. Chai and Y. Li: Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell Biol 45(9), 1962-73 (2013) DOI: 10.1016/j.biocel.2013.06.008
93. K. M. Lee, E. J. Choi and I. A. Kim: microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 101(1), 171-6 (2011) DOI: 10.1016/j.radonc.2011.05.050
94. L. Shi, J. Chen, J. Yang, T. Pan, S. Zhang and Z. Wang: MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352, 255-64 (2010) DOI: 10.1016/j.brainres.2010.07.009
95. H. S. Gwak, T. H. Kim, G. H. Jo, Y. J. Kim, H. J. Kwak, J. H. Kim, J. Yin, H. Yoo, S. H. Lee and J. B. Park: Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One 7(10), e47449 (2012) DOI: 10.1371/journal.pone.0047449
96. W. L. Ng, D. Yan, X. Zhang, Y. Y. Mo and Y. Wang: Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst) 9(11), 1170-5 (2010) DOI: 10.1016/j.dnarep.2010.08.007
97. L. Shi, S. Zhang, K. Feng, F. Wu, Y. Wan, Z. Wang, J. Zhang, Y. Wang, W. Yan, Z. Fu and Y. You: MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Int J Oncol 40(1), 119-29 (2012) Doi not found.
98. G. Chen, W. Zhu, D. Shi, L. Lv, C. Zhang, P. Liu and W. Hu: MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 23(4), 997-1003 (2010) Doi not found.
99. K. Ujifuku, N. Mitsutake, S. Takakura, M. Matsuse, V. Saenko, K. Suzuki, K. Hayashi, T. Matsuo, K. Kamada, I. Nagata and S. Yamashita: miR-195, miR-455-3p and miR-10a(∗) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 296(2), 241-8 (2010) DOI: 10.1016/j.canlet.2010.04.013
100. W. Q. Li, Y. M. Li, B. B. Tao, Y. C. Lu, G. H. Hu, H. M. Liu, J. He, Y. Xu and H. Y. Yu: Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Med Sci Monit 16(10), HY27-30 (2010) Doi not found.
101. H. Gal, G. Pandi, A. A. Kanner, Z. Ram, G. Lithwick-Yanai, N. Amariglio, G. Rechavi and D. Givol: MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun 376(1), 86-90(2008) Doi not found.